Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Increased Levels of Serum Tissue Inhibitor of Metalloproteinase-1 Correlate with Advanced Stage, Increased Bone Resorption, Lytic Bone Disease and Poor Survival in Newly-Diagnosed Myeloma Patients

Evangelos Terpos, Meletios A. Dimopoulos, Vikas Shrivastava, Kim Leitzel, Dimitrios Christoulas, Magdalini Migkou, Maria Gavriatopoulou, Konstantinos Anargyrou, Efstathios Kastritis, Allan Lipton

Blood (2008) 112 (11): 5143.

https://doi.org/10.1182/blood.V112.11.5143.5143

Published: 2008

Journal Articles

Predictors for Skeletal-Related Events in Patients with Advanced Multiple Myeloma.

Evangelos Terpos, Richard Cook, Robert Coleman, Allan Lipton, James Berenson

Blood (2007) 110 (11): 1482.

https://doi.org/10.1182/blood.V110.11.1482.1482

Published: 2007

Journal Articles

Increased Levels of Urinary N-Telopeptide of Type I Collagen Correlate with Reduced Survival in Patients with Advanced Multiple Myeloma.

James Berenson, Richard Cook, Allan Lipton, Robert Coleman, Evangelos Terpos

Blood (2007) 110 (11): 1499.

https://doi.org/10.1182/blood.V110.11.1499.1499

Published: 2007

Journal Articles

Elevated Serum Ras Levels in Patients with LGL Leukemia.

Erin M. Nelli, DO, Thomas P. Loughran, MD, Kim Leitzel, MSc, Suhail M. Ali, MD, Lawrence Demers, PhD, Walter P. Carney, PhD, Peter J. Hamer, MA, Allan Lipton, MD

Blood (2006) 108 (11): 4457.

https://doi.org/10.1182/blood.V108.11.4457.4457

Published: 2006

Journal Articles

Baseline N-Telopeptide Levels Correlate with Risk of Skeletal Morbidity in Patients with Multiple Myeloma during Zoledronic Acid Therapy.

Allan Lipton, Robert E. Coleman, Pierre Major, Janet E. Brown, Ker-Ai Lee, Matthew Smith, Fred Saad, YinMiao Chen, Yong Jiang, Hei, Richard Cook

Blood (2005) 106 (11): 3456.

https://doi.org/10.1182/blood.V106.11.3456.3456

Published: 2005

Journal Articles

Prognostic Significance of Biochemical Markers of Bone Metabolism in Patients with Bone Lesions from Multiple Myeloma (MM).

Richard J. Cook, Robert E. Coleman, Pierre Major, Allan Lipton, Janet E. Brown, Ker-Ai Lee, Matthew Smith, Fred Saad, YinMiao Chen, Yong Jiang Hei

Blood (2005) 106 (11): 5015.

https://doi.org/10.1182/blood.V106.11.5015.5015

Published: 2005

NARROW

Increased Levels of Serum Tissue Inhibitor of Metalloproteinase-1 Correlate with Advanced Stage, Increased Bone Resorption, Lytic Bone Disease and Poor Survival in Newly-Diagnosed Myeloma Patients

Predictors for Skeletal-Related Events in Patients with Advanced Multiple Myeloma.

Increased Levels of Urinary N-Telopeptide of Type I Collagen Correlate with Reduced Survival in Patients with Advanced Multiple Myeloma.

Elevated Serum Ras Levels in Patients with LGL Leukemia.

Baseline N-Telopeptide Levels Correlate with Risk of Skeletal Morbidity in Patients with Multiple Myeloma during Zoledronic Acid Therapy.

Prognostic Significance of Biochemical Markers of Bone Metabolism in Patients with Bone Lesions from Multiple Myeloma (MM).

Email alerts

ASH Publications

American Society of Hematology

Increased Levels of Serum Tissue Inhibitor of Metalloproteinase-1 Correlate with Advanced Stage, Increased Bone Resorption, Lytic Bone Disease and Poor Survival in Newly-Diagnosed Myeloma Patients

Predictors for Skeletal-Related Events in Patients with Advanced Multiple Myeloma.

Increased Levels of Urinary N-Telopeptide of Type I Collagen Correlate with Reduced Survival in Patients with Advanced Multiple Myeloma.

Elevated Serum Ras Levels in Patients with LGL Leukemia.

Baseline N-Telopeptide Levels Correlate with Risk of Skeletal Morbidity in Patients with Multiple Myeloma during Zoledronic Acid Therapy.

Prognostic Significance of Biochemical Markers of Bone Metabolism in Patients with Bone Lesions from Multiple Myeloma (MM).

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only